Jenburkt Pharmaceuticals has informed that a meeting of the Board of Directors of the Company is scheduled to be held on September 09, 2017, to consider matters related to Buyback of the fully paid-up equity shares of the Company including matters related/ incidental thereto and any other matter as the Board of Directors may decide during the course of the meeting.
The above information is a part of company’s filings submitted to BSE.